Based on the MetLife Inc stock forecast from 10 analysts, the average analyst target price for MetLife Inc is USD 91.21 over the next 12 months. MetLife Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of MetLife Inc is Bearish, which is based on 1 positive signals and 3 negative signals. At the last closing, MetLife Inc’s stock price was USD 81.71. MetLife Inc’s stock price has changed by -1.24% over the past week, -5.64% over the past month and +24.07% over the last year.
No recent analyst target price found for MetLife Inc
No recent average analyst rating found for MetLife Inc
Frequently Asked Questions About MetLife Inc (MET) Stock
Based on ratings from 10 analysts MetLife Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 19 buy, sell and hold ratings.
Unfortunately we do not have enough data on MET's stock to indicate if its a good dividend stock.
Based on targets from 10 analysts, the average taret price for MET is USD 91.21 over the next 12 months. The maximum analyst target price is USD 100 while the minimum anlayst target price is USD 83.
Unfortunately we do not have enough data on MET's stock to indicate if its overvalued.
The last closing price of MET's stock was USD 81.71.
Unfortunately we do not currently have any market capitalization data for MET's stock.
Based on targets from 10 analysts, the average taret price for MET is projected at USD 91.21 over the next 12 months.
This means that MET's stock price may go up by +11.63% over the next 12 months.
We can't find any ETFs which contains MetLife Inc's stock.
Sorry, we do not have any data on the number of employees for MetLife Inc.
Sorry we do not have any infomation available on MetLife Inc's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
What not to like
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About MetLife Inc (MET) Stock
Based on ratings from 10 analysts MetLife Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 19 buy, sell and hold ratings.
Unfortunately we do not have enough data on MET's stock to indicate if its a good dividend stock.
Based on targets from 10 analysts, the average taret price for MET is USD 91.21 over the next 12 months. The maximum analyst target price is USD 100 while the minimum anlayst target price is USD 83.
Unfortunately we do not have enough data on MET's stock to indicate if its overvalued.
The last closing price of MET's stock was USD 81.71.
Unfortunately we do not currently have any market capitalization data for MET's stock.
Based on targets from 10 analysts, the average taret price for MET is projected at USD 91.21 over the next 12 months.
This means that MET's stock price may go up by +11.63% over the next 12 months.
We can't find any ETFs which contains MetLife Inc's stock.
Sorry, we do not have any data on the number of employees for MetLife Inc.
Sorry we do not have any infomation available on MetLife Inc's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for MET !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
